Vaccine access amid political turmoil in Venezuela is the backdrop of institute director Richard Marlink’s comments, for a story published by Devex, about COVAX and a global response to the pandemic.
infectious diseases
The Results Are In
Three student teams were named winners of the first-ever Global Health Case Competition, a 10-week experience focused on the impact of COVID-19 on underserved communities in New Jersey.
Strong Show of Support for Health Equity in New Jersey
On Rutgers Giving Day, a 24-hour fundraising event, Rutgers Global Health Institute raised $18,870 to help confront health disparities in New Jersey.
The World According to COVID-19
It’s been a year since COVID-19 was declared a global pandemic. Rutgers Global Health Institute core faculty members discuss the health crisis in relation to their own areas of expertise and professional practice.
Rutgers professor discusses COVAX initiative, U.S. involvement
In an interview with The Daily Targum, institute director Richard Marlink explains the international collaboration to distribute COVID-19 vaccines more equitably worldwide.
Rutgers Global Health Institute Launches Program to Help Small Businesses Impacted by the COVID-19 Pandemic
The three-part program provides guidance on safe operations and related support services for small businesses and nonprofits in New Jersey’s low-income and minority communities.
Medical experts: J&J vaccine is just as effective as vaccines by Pfizer, Moderna
Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
Radio Interview: Marlink Discusses WHO, Vaccines, and COVAX
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.
The Impact of the U.S. Re-engaging with the World Health Organization
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Race to Vaccinate
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.